Journals / Fırat Tıp Dergisi / 2013 / Cilt: 18 - Sayı: 3

Sirtuin genes and functions

Sirtuin genleri ve işlevleri

Pages
136–140
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As a result of recent studies, in order to be able to study the role of SIRT genes on biological systems, which is providing positive results for the treatment of many diseases, it is important to understand the molecular and chemical structure of them.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Many studies have been conducted on the potential role, on several diseases, of 23 Sirtuin (SIRT) family genes known as NAD + dependent class III deacetylase enzymes.
📊
Key Findings & Data:Regarding the published literature, Sirtuins have been thought to play a significant role on the treatment of diabetes type II, obesity, cancer, aging, and several neuro-degenerative diseases.
💡
Conclusion & Impact:As a result of recent studies, in order to be able to study the role of SIRT genes on biological systems, which is providing positive results for the treatment of many diseases, it is important to understand the molecular and chemical structure of them.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Many studies have been conducted on the potential role, on several diseases, of 23 Sirtuin (SIRT) family genes known as NAD + dependent class III deacetylase enzymes. Regarding the published literature, Sirtuins have been thought to play a significant role on the treatment of diabetes type II, obesity, cancer, aging, and several neuro-degenerative diseases. As a result of recent studies, in order to be able to study the role of SIRT genes on biological systems, which is providing positive results for the treatment of many diseases, it is important to understand the molecular and chemical structure of them.

Özet

NAD + bağımlı sınıf III deasetilaz enzimler olarak bilinen Sirtuin (SIRT) ailesi genleri ile ilgili olarak çeşitli hastalıklardaki potansiyel rolü üzerine birçok çalışma yapılmıştır. Yayımlanmış literatüre dayanarak Sirtuinlerin; tip II diyabet, obezite, kanser, yaşlanma ve çeşitli nörodejeneratif hastalık- ların tedavisinde önemli rol oynadığı düşünülmektedir. Son yapılan çalışmalar sonucu birçok sağlık probleminin tedavisine yönelik olumlu sonuçlar veren SIRT genlerinin biyolojik sistemlerdeki rolünü çalışabilmek için moleküler ve kimyasal yapısını anlamak çok önemlidir.

🔖

Cite This Article

BAYRAM, A., İĞCİ, M. (2013). Sirtuin genes and functions. Fırat Tıp Dergisi, Cilt: 18 - Sayı: 3, 136–140. https://ajindex.com/articles/214781

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Bitterman KJ, Anderson RM, Cohen HY, Latorre-Esteves M, Sinclair DA. Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1. J Biol Chem 2002; 277: 45099-107.
  2. Klar AJ, Fogel S, Macleod K. MAR1-a Regulator of the HMa and HMalpha Loci in Saccharomyces cerevisiase. Genetics 1979; 93: 37-50.
  3. Michan S, Sinclair D. Sirtuins in mammals: insights into their biological function. Biochem J 2007; 404: 1-13.
  4. North BJ, Marshall BL, Borra MT, Denu JM, Verdin E. The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Mol Cell 2003; 11: 437-44.
  5. Haigis MC, Mostoslavsky R, Haigis KM, et al. SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells. Cell 2006; 126: 941-54.
  6. Shi T, Wang F, Stieren E, Tong Q. SIRT3, a mitochondrial sirtuin deacetylase, regulates mitochondrial function and ther- mogenesis in brown adipocytes. J Biol Chem 2005; 280: 13560-7.
  7. Glozak AM, Sengupta N, Zhang X, Seto E. Acetylation and deacetylation of non-histone proteins. Gene 2005; 363: 15-23.
  8. Taddei A, Roche D, Bickmore WA, Almouzni G. The effects of histone deacetylase inhibitors on heterochromation: impli- cations for anti-cancer therapy? EMBO Reports 2005; 6: 520- 4. Gray GS, Ekström JT, The humanExp Cell Res 2001; 262: 75-83. histone deacetylase family. Bae NS, Swanson MJ, Vassilev A, Howard BH. Human histone deacetylase SIRT2 interacts with the homeobox transc- ription factor HOXA10. J Biochem 2004; 135: 695-700.
  9. Chen WY, Wang DH, Yen RC, Luo J, Gu W, Baylin SB. Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses. Cell 2005; 123: 437- 48. Muth V, Nadaud S, Grummt I, Voit R. Acetylation of TAF(I)68, a subunit of TIF-IB/SL1, activates RNA polymera- se I transcription. Embo J 2001; 20: 1353-62.
  10. Bouras T, Fu M, Sauve AA, et al. SIRT1 deacetylation and repression of p300 involves lysine residues 1020/1024 within the cell cycle regulatory domain 1. J Biol Chem 2005; 280: 10264-76.
  11. Ashraf N, Zino S, Macintyre A, Kingsmore D, Payne AP, George WD, Shiels PG. Altered sirtuin expression is associa- ted with node-positive breast cancer. Br J Cancer 2006; 95: 1056–61.
  12. Vakhrusheva O, Smolka C, Gajawada P, et al. Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice. Circ Res 2008; 102: 703-10. de Nigris F, Cerutti J, Morelli C, et al. Isolation of a SIR-like gene, SIR-T